Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
Yuanqiang Ma, Gyurim Lee, Suyoung Heo, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 91-91
Open Access | Times Cited: 134

Showing 26-50 of 134 citing articles:

NLRP3 Inflammasome in Acute and Chronic Liver Diseases
Katia Sayaf, Sara Battistella, Francesco Paolo Russo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4537-4537
Open Access | Times Cited: 8
Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease
Alessio Carmignani, Matteo Battaglini, Martina Bartolucci, et al.
Materials & Design (2024) Vol. 239, pp. 112825-112825
Open Access | Times Cited: 7
Design, synthesis, and biological evaluation of first-in-class FABP1 inhibitors for the treatment of NASH
Ya Chen, Mingyang Yu, Lianru Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116358-116358
Closed Access | Times Cited: 7
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?
Aurelio Seidita, Alessandra Cusimano, Alessandra Giuliano, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 731-731
Open Access | Times Cited: 6
Managing metabolic diseases: The roles and therapeutic prospects of herb-derived polysaccharides
Xinmei Xu, Lijie Wang, Kun Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114538-114538
Open Access | Times Cited: 16
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
Camelia Munteanu, Betty Schwartz
Antioxidants (2023) Vol. 12, Iss. 4, pp. 903-903
Open Access | Times Cited: 13
Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function
Xuemei Wang, Jieying Wang, Ying Cao, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study
Maria Magdalena Quetglas‐Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 480-480
Open Access | Times Cited: 6
Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats
Maoxing Pan, Yuanjun Deng, Yebei Qiu, et al.
Phytomedicine (2024) Vol. 130, pp. 155712-155712
Closed Access | Times Cited: 6
Effect of three different insect larvae on growth performance and antioxidant activity of thigh, breast, and liver tissues of chickens reared under mild heat stress
Stylianos Vasilopoulos, Ιlias Giannenas, Ioannis Panitsidis, et al.
Tropical Animal Health and Production (2024) Vol. 56, Iss. 2
Open Access | Times Cited: 5
Thiobencarb induces phenotypic abnormalities, apoptosis, and cardiovascular toxicity in zebrafish embryos through oxidative stress and inflammation
Garam An, Junho Park, Whasun Lim, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2022) Vol. 261, pp. 109440-109440
Closed Access | Times Cited: 21
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease
Qiang Ren, Ya Chen, Zongtao Zhou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6082-6104
Closed Access | Times Cited: 13
Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats
Alaa Hasanain Felemban, Ghedeir M. Alshammari, Abu ElGasim A. Yagoub, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1471-1471
Open Access | Times Cited: 12
Rising Influence of Nanotechnology in Addressing Oxidative Stress-Related Liver Disorders
Padmanaban Sathiyamoorthy, Durgasruthi Pully, Antony V. Samrot, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1405-1405
Open Access | Times Cited: 12
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model
Phoebe Ohene-Marfo, Hoang Van M. Nguyen, Sabira Mohammed, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2813-2813
Open Access | Times Cited: 4
TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation
Xiaomian Li, Wenzhi He, Xi Chen, et al.
Oncogene (2024) Vol. 43, Iss. 27, pp. 2063-2077
Closed Access | Times Cited: 4
Gut microbiota and immunity in health and diseases: a review
Michael Chukwuma Okolie, Great Iruoghene Edo, Irene Ebosereme Ainyanbhor, et al.
DELETED (2024)
Closed Access | Times Cited: 4
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review
Gabriela Svobodová, Martin Horní, Eva Velecká, et al.
Archives of Toxicology (2024)
Open Access | Times Cited: 4
Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases
Eungyeong Jang
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1437-1437
Open Access | Times Cited: 17
Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
Madalina Andreea Robea, Ioana-Miruna Balmuș, Irina Gîrleanu, et al.
Medicina (2023) Vol. 59, Iss. 9, pp. 1614-1614
Open Access | Times Cited: 10
Chemical Characterization and Differential Lipid-Modulating Effects of Selected Plant Extracts from Côa Valley (Portugal) in a Cell Model for Liver Steatosis
Ricardo Amorim, Mário Pedro Marques, Catarina Melim, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 39-39
Open Access
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
Vittoria Cammisotto, Emanuele Valeriani, Pasquale Pignatelli, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 83-83
Open Access
Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Non-Alcoholic Steatohepatitis with a Focus on the AMPK/Nrf2 Signaling Axis
Soha S. Zakaria, Safaa M. Hanafy
Medicina (2025) Vol. 61, Iss. 1, pp. 139-139
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Ionescu, Gina Gheorghe, Nicolae Bacalbașa, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 163-163
Open Access
β-Carotene-loaded cationic nanoparticles ameliorate MASLD via modulating lipid homeostasis and gut microbiome
Lan‐Feng Dong, Wen‐Yong Lou, Juan Wang
Food Research International (2025) Vol. 205, pp. 115816-115816
Closed Access

Scroll to top